Tyra Biosciences (TYRA) Interest & Investment Income (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Interest & Investment Income data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Interest & Investment Income fell 27.28% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (down 31.74% YoY) and the FY2025 annual result came in at $12.8 million, down 27.58% from the prior year.
• Interest & Investment Income steadied at $2.7 million in Q1 2026, from $2.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $4.8 million in Q2 2024 to a low of $18000.0 in Q1 2022.
• A 5-year average of $2.8 million and a median of $2.8 million in 2023 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 56450.0% — and 2025, when it slumped 35.73%.
• Tracing TYRA's Interest & Investment Income over 5 years: stood at $2.2 million in 2022, then jumped by 30.06% to $2.8 million in 2023, then jumped by 48.82% to $4.2 million in 2024, then tumbled by 35.73% to $2.7 million in 2025, then grew by 0.41% to $2.7 million in 2026.
• The last three Interest & Investment Income figures came in at $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.